Just looked at the 2Q presentation. I haven't listened to the call yet. Here are the items that caught my eye...1: Asia is now 11% of revenues, but grew 54% Year-over-year. There is huge growth in asia for QGEN going forward. They are very well positioned in China.2: 19% revenue growth Y-O-Y across all regions, 30% in net income growth, 23% growth in EPS. 3: 550 Million in current assets and 1.2 billion in debt for the combined company. Fair amount of debt on books but it looks like net debt is around 700 M. 4: 518 M-535 M old guidence for revenue in 2H07, New guidence for combined company is 614 - 635 M. Not sure if that excludes/includes month of July for Digene. 5: 2,017 employees at end of Q2 including 362 in asia (216 in sales in asia). Now company has over 2,600 employees post merger.
Good analysis. If you like at analyst forecasts for the HPV market, worldwide, they expect QGEN to grow from $350million in molecular diagnostic sales to $1 billion by 2012. That is huge growth. Jump on board now because the ride has started.